Synopsys (NASDAQ:SNPS) just handed AMD (NASDAQ:AMD) and Microsoft (NASDAQ:MSFT) a new way to design chips: let AI agents do more of the work. On July 27, Synopsys unveiled autonomous agentic AI workflows built with Microsoft and already being evaluated by AMD, aimed at cutting the time it takes to turn a chip specification into working silicon. The announcement lands as investors weigh whether Synopsys deserves its premium for owning so much of the AI buildout’s tooling.
Bull Case: Agents Doing The Engineering, Not Just The Typing
Synopsys introduced two autonomous workflows at the DAC Chips to Systems Conference, developed with Microsoft and available for evaluation on Microsoft Discovery. One handles debug closure, using domain-specific and task-level agents to find design failures and speed up validation, with early evaluations showing a 25% to 40% reduction in debug cycle time. The other automates implementation and closure work on Synopsys’ Fusion Compiler on Azure, with early results pointing to improved quality of results. AMD is actively evaluating these workflows for its next-generation products.
That traction fits a broader pattern. Synopsys already counts Nvidia (NASDAQ:NVDA) as both a customer and an investor, after Nvidia expanded its partnership with a $2 billion investment. Synopsys’ design software and intellectual property make it hard for rivals to dislodge once a chipmaker builds a project around its tools, and that stickiness showed up in the numbers: fiscal 2026 second quarter revenue grew 42% year-over-year, prompting the company to raise its full-year guidance.
Bear Case: The Ansys Bill Is Still Coming Due
Despite that growth, Synopsys shares had fallen 12% year to date as of July 16, a gap one analysis called jarring given the company’s market share gains. Part of the explanation sits inside the Ansys deal: Synopsys paid $35 billion for it, and the resulting amortization costs have kept margins tight, with relief only expected once those costs wind down. Stock-based compensation made up roughly 58.8% of Synopsys’ operating cash flow in fiscal 2025, meaning a large share of its reported free cash flow, about $1.3 billion for the year, comes from a non-cash add-back rather than actual cash generation.
There are also risks outside the balance sheet. Synopsys is managing multiple class action lawsuits alleging misstatements about its intellectual property segment, and a settlement with Elliott Investment Management could still push the company toward strategic changes.
Where Street Money Sits Right Now
Hedge fund ownership of Synopsys fell from 91 funds to 84 in the most recent quarter, a pullback that suggests some institutional money trimmed positions. Short interest sits at just 2.94% of float, low enough to signal little organized skepticism. Synopsys trades at a forward price-to-earnings ratio of 24.10 as of August 7, a multiple that assumes solid growth continues without being stretched to extreme levels.
What Would Have To Go Right, Or Wrong, From Here
Synopsys sits at a crossroads. The bull case rests on real traction, from the AMD and Microsoft collaboration to double-digit revenue growth, while the bear case rests on margin pressure and legal overhang tied to Ansys. For the growth story to win out, the new workflows need to convert from evaluations into paying deployments.
While we acknowledge the risk and potential of SNPS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than SNPS and that has 10,000% upside potential, check out our report about this cheapest AI stock.
READ NEXT: 10 Best Future Stocks to Buy Under $10 and 12 Best Performing Semiconductor Stocks to Invest In.
Disclosure: None. Follow Insider Monkey on Google News.
Hedge Fund Resource Center